Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drug

Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drug - Effect of the Integrated Approach to Symptom Management for skin toxicity associated with molecularly targeted drug

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016947

Enrollment

Registered

2015-04-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin toxicity associated with molecularly targeted drug

Interventions

Period: to March 31st 2016 Frequency : 4 times First Intervention: 1)Interview according to guide book. Conduct observation of skin condition. Measure the outcome scales. 2)Understand the symptom

s symptom experience. 2)Positive feedback. 3)Practice the above 3)4)5). Final Intervention: 1)Review and share the process for 6 weeks. 2)Recognize and identify patient&#39

s effort and make sure their achievement. 3)Measure the outcome scales.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Out patients who have skin toxicity associated with Epidermal growth factor receptor (EGFR) inhibitors or multikinase inhibitors. 2) Patients who have the ability to communicate in Japanese and to respond to the questionnaire without any cognitive disability.

Exclusion criteria

Exclusion criteria: Patients who cannot communicate in Japanese and be described to understand the contents of the questionnaire.

Design outcomes

Primary

Measure	Time frame
skin condition (adverse events of skin)	—

Secondary

Measure	Time frame
self-efficacy scale for cancer patients Skindex29 self-care ability (scale)	—

Countries

Japan

Contacts

Public ContactMasamichi Fukuda

University of Hyogo College of Nursing

masamichi_fukuda@cnas.u-hyogo.ac.jp078-925-9434

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Examine the patient&#39;s response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drug